Obesity-mediated regulation of HGF/c-met is associated with reduced basal-like breast cancer latency in Parous mice

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Sundaram, Sneha ^b   Freemerman, Alex J ^b   Galanko, Joseph A ^a   McNaughton, Kirk K ^a   Bendt, Katharine M ^a   Darr, David B ^a   Troester, Melissa A ^a   Makowski, Liza ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GLUCOSE; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGESTERONE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; HGF PROTEIN, MOUSE;

AFRICAN AMERICAN; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BASAL LIKE BREAST CANCER; BODY COMPOSITION; BODY WEIGHT; CANCER RISK; COCULTURE; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LATENT PERIOD; LIPID DIET; MAMMARY GLAND; MOUSE; NONHUMAN; NULLIPARA; OBESITY; PARITY; PREGNANCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; BLOOD; COMPLICATION; EXPERIMENTAL MAMMARY NEOPLASM; GENETICS; METABOLISM; PATHOLOGY; TIME FACTOR;

MUS;

ANIMALS; FEMALE; HEPATOCYTE GROWTH FACTOR; INTERLEUKIN-6; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; OBESITY; PARITY; TIME FACTORS;

EID: 84908568810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111394     Document Type: Article

References (53)

1. Albrektsen G, Heuch I, Kvale G (1995) The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 72: 480-484.
2. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, et al. (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355: 560-569.
3. CGAN (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
4. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, et al. (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8: R76.
5. Toft DJ, Cryns VL (2011) Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies. Molecular Endocrinology 25: 199-211.
6. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497.
7. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, et al. (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109: 123-139.
8. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, et al. (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295: 2492-2502.
9. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, et al. (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13: 1558-1568.
10. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention 17: 2078-2086.
11. Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, et al. (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11: R31.
12. Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, et al. (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20: 1071-1082.
13. Medina D, Smith GH (1999) Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J Natl Cancer Inst 91: 967-969.
14. Sinha DK, Pazik JE, Dao TL (1988) Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. Br J Cancer 57: 390-394.
15. Inano H, Suzuki K, Ishii-Ohba H, Ikeda K, Wakabayashi K (1991) Pregnancydependent initiation in tumorigenesis of Wistar rat mammary glands by 60 Coirradiation. Carcinogenesis 12: 1085-1090.
16. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, et al. (1998) Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis 19: 1573-1581.
17. Camp JT, Elloumi F, Roman-Perez E, Rein J, Stewart DA, et al. (2011) Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers. Mol Cancer Res 9: 3-13.
18. Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer HA, McNaughton K, et al. (2013) Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res 15: R82.
19. Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, et al. (2013) Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res 19: 571-585.
20. Stewart DA, Yang Y, Makowski L, Troester MA (2012) Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages. Molecular Cancer Research 10: 727-738.
21. Sundaram S, Le TL, Essaid L, Freemerman AJ, Huang MJ, et al. (2014) Weight loss reversed obesity-induced HGF/c-Met pathway and basal-like breast cancer progression. Frontiers in Oncology 4.
22. Sundaram S, Freemerman AJ, Johnson AR, Milner JJ, McNaughton KK, et al. (2013) Role of HGF in obesity-associated tumorigenesis: C3(1)-T mice as a model for human basal-like breast cancer. Breast Cancer Res Treat.
23. Gatenby RAG, Brown RJ, Joel S. (2011) Of cancer and cave fish. Nature Publishing group 11: 237-238.
24. Troester MA, Lee MH, Carter M, Fan C, Cowan DW, et al. (2009) Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 15: 7020-7028.
25. Keppel KG, Taffel SM (1993) Pregnancy-related weight gain and retention: implications of the 1990 Institute of Medicine guidelines. Am J Public Health 83: 1100-1103.
26. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591.
27. Carmichael AR (2006) Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 113: 1160-1166.
28. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, et al. (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278: 1407-1411.
29. Ursin G, Longnecker MP, Haile RW, Greenland S (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6: 137-141.
30. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, et al. (2007) Differences in risk factors for breast cancer molecular subtypes in a populationbased study. Cancer Epidemiol Biomarkers Prev 16: 439-443.
31. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296: 193-201.
32. Michels KB, Terry KL, Eliassen AH, Hankinson SE, Willett WC (2012) Adult weight change and incidence of premenopausal breast cancer. Int J Cancer 130: 902-909.
33. Key TJ, Allen NE, Verkasalo PK, Banks E (2001) Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60: 81-89.
34. Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, et al. (2000) The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19: 1020-1027.
35. Sundaram S, Freemerman AJ, Johnson AR, Milner JJ, McNaughton KK, et al. (2013) Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer. Breast Cancer Res Treat 142: 489-503.
36. Sundaram S, Freemerman AJ, McNaughton KK, Galanko JA, Bendt KM, et al. (2013) Role of HGF in obesity-associated tumorigenesis: C3(1)-Tag mice as a model for human basal-like breast cancer. Cancer Prev Res (Phila) Under Review.
37. Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer HA, McNaughton KK, et al. (2013) Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Research.
38. Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, et al. (2011) Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) 19: 1109-1117.
39. Tiede B, Kang Y (2011) From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res 21: 245-257.
40. Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen DB, et al. (1999) Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicological Sciences 51: 236-244.
41. Engineer DR, Garcia JM (2012) Leptin in Anorexia and Cachexia Syndrome. International Journal of Peptides 2012.
42. Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 307: 483-490.
43. Brisken C, O'Malley B (2010) Hormone Action in the Mammary Gland. Cold Spring Harbor Perspectives in Biology 2.
44. Watson C (2006) Key stages in mammary gland development - Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Research 8: 203.
45. Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, et al. (2012) Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 131: 1003-1012.
46. Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, et al. (2011) Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer. Cancer Prevention Research 4: 1021-1029.
47. Bhardwaj P, Du B, Zhou XK, Sue E, Harbus MD, et al. (2013) Caloric restriction reverses obesity-induced mammary gland inflammation in mice. Cancer Prev Res (Phila) 6: 282-289.
48. Sampey BP, Freemerman AJ, Zhang J, Kuan PF, Galanko JA, et al. (2012) Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 7: e38812.
49. Birchmeier C, Gherardi E (1998) Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends in Cell Biology 8: 404-410.
50. Gastaldi S, Comoglio P, Trusolino L (2010) The Met oncogene and basal-like breast cancer: another culprit to watch out for? Breast Cancer Research 12: 208.
51. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925.
52. Xue F, Michels K (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J ClinNutr 86: s823-s835.
53. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE (2007) Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16: 161-164.